It is a agriculture private limited company based in Patancheru, Telangana, India, established in 2000.
2000 | Patancheru, Telangana, India | ActiveShivshakti Drugs Private Limited, a active private limited company, was established on 14 June 2000 in Patancheru, Telangana, India. Engaging in sugar processing within the manufacturing sector, it holds CIN: U74110TG2000PTC034665. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹5.00 M.
Formerly known as Shivshakti Drugs Private Limited, Shivshakti Lifesciences Private Limited. It upholds a compliant status. Its leadership includes Krishnadevi Pavankumar Agrawal (Director), Pawankumar Dwarkaprasad Agrawal (Director). Past directors included Naresh Dhanrajbhai Kella, Krishnadevi Pavankumar Agrawal, Lalit Dhanrajbhai Kella. It holds no open charges and ₹3.40 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 31 Ground Floor, Prathima Estate, Survey No 180/1,180/2,180/3,180/9 And 180/10, Patancheru, Telangana, 502319.
U74110TG2000PTC034665
034665
14 June 2000
₹8.00 M
₹5.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Shivshakti Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnadevi Pavankumar Agrawal | Director | 16 Jun 2015 | Current |
| Pawankumar Dwarkaprasad Agrawal | Director | 30 Jan 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Mar 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 08 Mar 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shivshakti Drugs Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 15.29% decrease. The company also saw a substantial fall in profitability, with a 79.73% decrease in profit. The company's net worth moved up by a moderate rise of 7.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Shivshakti Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹33,950,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2016 | Hdfc Bank Limited | ₹5.00 M | Satisfied |
| 03 Feb 2014 | The A.P. Mahesh Co-Op Urban Bank Limited | ₹1.35 Cr | Satisfied |
| 02 Jun 2007 | Hdfc Bank Limited | ₹0.45 M | Satisfied |
| 14 Nov 2006 | The A.P.Mahesh Co-Operative Urban Bank Limited | ₹1.50 Cr | Satisfied |
| 18 Jan 2003 | A.P. State Financial Corporation | ₹0.00 | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shivshakti Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shivshakti Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivshakti Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shivshakti Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Shivshakti Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity A charge registered on 02 Jun 2007 via Charge ID 10055955 with Hdfc Bank Limited was fully satisfied on 15 Sep 2020. was completed.
Progress on A charge registered on 23 Dec 2016 via Charge ID 100074051 with Hdfc Bank Limited was fully satisfied on 26 Aug 2020. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 5.00 M with Charge ID 100074051 was registered on 23 Dec 2016. was recorded as a recent event.
Progress on A charge registered on 03 Feb 2014 via Charge ID 10507248 with The A.P. Mahesh Co-Op Urban Bank Limited was fully satisfied on 09 Aug 2016. was documented.
The CIN of Shivshakti Drugs Private Limited is U74110TG2000PTC034665.
Shivshakti Drugs Private Limited is headquartered at Plot No 31 Ground Floor, Prathima Estate, Survey No 180/1,180/2,180/3,180/9 And 180/10, Patancheru, Telangana, 502319.
Shivshakti Drugs Private Limited was incorporated on 14 June 2000.
The current directors of Shivshakti Drugs Private Limited are
The primary industry of Shivshakti Drugs Private Limited is Manufacturing.
Shivshakti Drugs Private Limited is unlisted.
The authorized capital of Shivshakti Drugs Private Limited is ₹8.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Shivshakti Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX